LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings
AUM
$11.3B
1-Year Return
14.72%
This Quarter Return
+1.18%
1 Year Return
+14.72%
3 Year Return
+73.17%
5 Year Return
+113.06%
10 Year Return
+348.26%
AUM
$10.9B
AUM Growth
+$798M
(+7.9%)
Cap. Flow
+$15.5M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
46.55%
Holding
592
New
29
Increased
95
Reduced
165
Closed
41
Top Buys
| 1 |
Synopsys
SNPS
|
$40.4M |
| 2 |
Veeva Systems
VEEV
|
$24.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$18M |
| 4 |
Paycom
PAYC
|
$14.8M |
| 5 |
WEX
WEX
|
$9.15M |
Top Sells
| 1 |
Microsoft
MSFT
|
$11.9M |
| 2 |
Mastercard
MA
|
$10.1M |
| 3 |
Intuit
INTU
|
$9.72M |
| 4 |
Apple
AAPL
|
$8.85M |
| 5 |
NXP Semiconductors
NXPI
|
$7.48M |
Sector Composition
| 1 | Technology | 40.18% |
| 2 | Healthcare | 16.5% |
| 3 | Consumer Discretionary | 10.28% |
| 4 | Financials | 9.32% |
| 5 | Communication Services | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Snowflake
SNOW
$75.1B
| $1.01M | 0.01% |
7,400
| – | – |
|
152
General Mills
GIS
$26.9B
| $1M | 0.01% |
15,970
-226
| -1% | -$14.2K |
|
153
Mettler-Toledo International
MTD
$26.8B
| $989K | 0.01% |
715
| – | – |
|
154
Vanguard Growth ETF
VUG
$188B
| $976K | 0.01% |
2,523
-10
| -0.4% | -$3.87K |
|
155
Moody's
MCO
$89.8B
| $969K | 0.01% |
2,143
-20
| -0.9% | -$9.05K |
|
156
Boeing
BA
$172B
| $959K | 0.01% |
5,153
+70
| +1% | +$13K |
|
157
Comcast
CMCSA
$126B
| $924K | 0.01% |
23,335
-1,042
| -4% | -$41.3K |
|
158
iShares Core S&P 500 ETF
IVV
$668B
| $920K | 0.01% |
1,619
-113
| -7% | -$64.2K |
|
159
Corning
GLW
$60.3B
| $909K | 0.01% |
19,678
| – | – |
|
160
Caterpillar
CAT
$198B
| $891K | 0.01% |
2,470
+1,400
| +131% | +$505K |
|
161
iShares Russell 2000 ETF
IWM
$68.1B
| $857K | 0.01% |
3,817
-75
| -2% | -$16.8K |
|
162
Netflix
NFLX
$530B
| $847K | 0.01% |
1,290
| – | – |
|
163
McKesson
MCK
$85.1B
| $846K | 0.01% |
1,449
| – | – |
|
164
Perrigo
PRGO
$3.23B
| $840K | 0.01% |
+31,000
| New | +$840K |
|
165
Bristol-Myers Squibb
BMY
$95.5B
| $832K | 0.01% |
20,198
-2,164
| -10% | -$89.2K |
|
166
Novartis
NVS
$252B
| $829K | 0.01% |
7,496
+400
| +6% | +$44.2K |
|
167
Marsh & McLennan
MMC
$102B
| $824K | 0.01% |
3,766
-47
| -1% | -$10.3K |
|
168
Vanguard FTSE Developed Markets ETF
VEA
$172B
| $807K | 0.01% |
15,704
-4,208
| -21% | -$216K |
|
169
Simon Property Group
SPG
$60B
| $800K | 0.01% |
5,279
| – | – |
|
170
Enbridge
ENB
$105B
| $798K | 0.01% |
22,153
-3,000
| -12% | -$108K |
|
171
Sherwin-Williams
SHW
$93.2B
| $778K | 0.01% |
2,383
+42
| +2% | +$13.7K |
|
172
Fastenal
FAST
$55.7B
| $778K | 0.01% |
22,530
| – | – |
|
173
iShares Core S&P Small-Cap ETF
IJR
$86.5B
| $766K | 0.01% |
6,556
-223
| -3% | -$26.1K |
|
174
Vanguard Ultra-Short Bond ETF
VUSB
$5.47B
| $763K | 0.01% |
15,400
+6,070
| +65% | +$301K |
|
175
Agilent Technologies
A
$36.8B
| $754K | 0.01% |
5,540
-52
| -0.9% | -$7.08K |
|